North Carolina regulators approve a moderated 5% average increase in automobile insurance rates for fall 2024, significantly lower than the 23% initially requested by insurers. Key insights into state-level regulatory impact.
Pfizer and other pharmaceutical firms have discussed most-favored-nation drug pricing with the U.S. government, highlighting potential impacts on insurance and payer strategies.
APCIA reports $8 billion in hurricane claims settled, defending industry's response amid Senate subcommittee scrutiny over State Farm and Allstate claims practices.
President Trump's executive order and CMS initiatives mark significant moves to reduce drug prices through broadened Medicare price negotiations including Part B drugs, impacting pharmaceutical industry dynamics and regulatory compliance.
President Trump announces an executive order aiming to reduce U.S. prescription drug prices by 30-80% through a 'Most Favored Nation' pricing policy affecting healthcare and insurance markets.
NAIFA prioritizes extending key Tax Cuts and Jobs Act provisions impacting life insurance and small business tax benefits, opposing C-SALT deduction limits, and promoting regulatory stability in Medicare and insurance markets.
Wyoming's Supreme Court debates whether abortion is healthcare, impacting regulations and healthcare rights. This case exemplifies the broader discourse on reproductive health governance in the U.S.
